Dr Mohty on the Promise of Elranatamab in Relapsed/Refractory Multiple Myeloma
August 3rd 2023Mohamad Mohty, MD, PhD, discusses the promise of the phase 2 MagnetisMM-3 trial in patients with relapsed/refractory multiple myeloma, which is investigating elranatamab monotherapy in this patient population.
Read More